Intro

This chapter explores the current challenges and advancements in the gene therapy sector while highlighting insights from a recent conference. The discussion shifts from lighthearted sports banter to serious biotech issues, including mergers, executive changes, and FDA updates, alongside a look at New York City's status as a life sciences hub.